vs

Side-by-side financial comparison of HERITAGE FINANCIAL CORP (HFWA) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $66.3M, roughly 1.3× HERITAGE FINANCIAL CORP). HERITAGE FINANCIAL CORP runs the higher net margin — 33.5% vs -38.1%, a 71.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 16.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 16.8%).

Heritage Financial Corp (WA) is a U.S. regional financial holding company headquartered in Washington state. It provides comprehensive commercial and consumer banking services, including deposit products, small business loans, residential mortgages, personal lending and wealth management solutions, primarily serving local communities across the Pacific Northwest, with core customer segments covering small-to-medium enterprises and retail clients.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

HFWA vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.3× larger
PRCT
$83.1M
$66.3M
HFWA
Growing faster (revenue YoY)
PRCT
PRCT
+3.9% gap
PRCT
20.2%
16.3%
HFWA
Higher net margin
HFWA
HFWA
71.6% more per $
HFWA
33.5%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
16.8%
HFWA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HFWA
HFWA
PRCT
PRCT
Revenue
$66.3M
$83.1M
Net Profit
$22.2M
$-31.6M
Gross Margin
64.9%
Operating Margin
38.7%
-4.1%
Net Margin
33.5%
-38.1%
Revenue YoY
16.3%
20.2%
Net Profit YoY
86.4%
-27.9%
EPS (diluted)
$0.65
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HFWA
HFWA
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$66.3M
$76.4M
Q3 25
$65.7M
$83.3M
Q2 25
$56.5M
$79.2M
Q1 25
$57.6M
$69.2M
Q4 24
$57.1M
$68.2M
Q3 24
$54.8M
$58.4M
Q2 24
$56.4M
$53.4M
Net Profit
HFWA
HFWA
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$22.2M
$-29.8M
Q3 25
$19.2M
$-21.4M
Q2 25
$12.2M
$-19.6M
Q1 25
$13.9M
$-24.7M
Q4 24
$11.9M
$-18.9M
Q3 24
$11.4M
$-21.0M
Q2 24
$14.2M
$-25.6M
Gross Margin
HFWA
HFWA
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
HFWA
HFWA
PRCT
PRCT
Q1 26
-4.1%
Q4 25
38.7%
-40.6%
Q3 25
34.0%
-27.8%
Q2 25
25.6%
-28.0%
Q1 25
28.1%
-39.7%
Q4 24
28.6%
-28.9%
Q3 24
23.8%
-38.4%
Q2 24
28.4%
-50.3%
Net Margin
HFWA
HFWA
PRCT
PRCT
Q1 26
-38.1%
Q4 25
33.5%
-39.1%
Q3 25
29.2%
-25.7%
Q2 25
21.6%
-24.7%
Q1 25
24.2%
-35.8%
Q4 24
20.9%
-27.6%
Q3 24
20.8%
-35.9%
Q2 24
25.1%
-48.0%
EPS (diluted)
HFWA
HFWA
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.65
$-0.54
Q3 25
$0.55
$-0.38
Q2 25
$0.36
$-0.35
Q1 25
$0.40
$-0.45
Q4 24
$0.34
$-0.34
Q3 24
$0.33
$-0.40
Q2 24
$0.41
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HFWA
HFWA
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$233.1M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$921.5M
$347.7M
Total Assets
$7.0B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HFWA
HFWA
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$233.1M
$286.5M
Q3 25
$245.5M
$294.3M
Q2 25
$254.1M
$302.7M
Q1 25
$248.7M
$316.2M
Q4 24
$117.1M
$333.7M
Q3 24
$175.6M
$196.8M
Q2 24
$113.8M
$214.1M
Total Debt
HFWA
HFWA
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
HFWA
HFWA
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$921.5M
$365.9M
Q3 25
$904.1M
$380.3M
Q2 25
$888.2M
$385.8M
Q1 25
$881.5M
$389.2M
Q4 24
$863.5M
$402.2M
Q3 24
$874.5M
$241.2M
Q2 24
$850.5M
$251.8M
Total Assets
HFWA
HFWA
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$7.0B
$508.1M
Q3 25
$7.0B
$511.5M
Q2 25
$7.1B
$513.1M
Q1 25
$7.1B
$519.4M
Q4 24
$7.1B
$534.0M
Q3 24
$7.2B
$374.1M
Q2 24
$7.1B
$374.4M
Debt / Equity
HFWA
HFWA
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HFWA
HFWA
PRCT
PRCT
Operating Cash FlowLast quarter
$94.8M
Free Cash FlowOCF − Capex
$85.7M
FCF MarginFCF / Revenue
129.1%
Capex IntensityCapex / Revenue
13.8%
Cash ConversionOCF / Net Profit
4.26×
TTM Free Cash FlowTrailing 4 quarters
$149.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HFWA
HFWA
PRCT
PRCT
Q1 26
Q4 25
$94.8M
$-10.3M
Q3 25
$25.1M
$-6.6M
Q2 25
$22.5M
$-15.0M
Q1 25
$19.3M
$-17.0M
Q4 24
$64.5M
$-32.4M
Q3 24
$24.2M
$-18.8M
Q2 24
$6.8M
$-15.7M
Free Cash Flow
HFWA
HFWA
PRCT
PRCT
Q1 26
Q4 25
$85.7M
$-12.2M
Q3 25
$24.4M
$-9.5M
Q2 25
$20.9M
$-17.8M
Q1 25
$18.1M
$-18.8M
Q4 24
$61.0M
$-33.6M
Q3 24
$23.2M
$-19.0M
Q2 24
$6.0M
$-16.8M
FCF Margin
HFWA
HFWA
PRCT
PRCT
Q1 26
Q4 25
129.1%
-15.9%
Q3 25
37.1%
-11.4%
Q2 25
37.0%
-22.5%
Q1 25
31.4%
-27.2%
Q4 24
107.0%
-49.2%
Q3 24
42.4%
-32.6%
Q2 24
10.6%
-31.4%
Capex Intensity
HFWA
HFWA
PRCT
PRCT
Q1 26
Q4 25
13.8%
2.4%
Q3 25
1.0%
3.4%
Q2 25
2.8%
3.5%
Q1 25
2.0%
2.7%
Q4 24
6.1%
1.7%
Q3 24
1.7%
0.4%
Q2 24
1.5%
2.0%
Cash Conversion
HFWA
HFWA
PRCT
PRCT
Q1 26
Q4 25
4.26×
Q3 25
1.31×
Q2 25
1.84×
Q1 25
1.38×
Q4 24
5.41×
Q3 24
2.12×
Q2 24
0.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HFWA
HFWA

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons